In 2026, growth in the sports and active nutrition category is being driven by science‑backed formulations, tech and AI, target audience expansions, innovative formats, biohacking solutions, and increasing regulatory and dosing scrutiny. In this pillar of presentations and discussions, we will provide a comprehensive overview of where the industry stands today, key challenges for industry players, and where the most promising opportunities lie next. 

More panellists to be confirmed

With performance‑focused nutrition now reaching wider demographics, brands are innovating beyond traditional macronutrient strategies. This session examines the latest science and commercial potential behind key performance‑driving ingredients, such as; advanced protein formulations, clinically supported creatine, collagen for joint and connective tissue health, and emerging ergogenic compounds from functional mushrooms. Discussions will highlight formulation challenges, bioavailability, regulatory considerations, and consumer education.

More speakers to be confirmed

More panellists to be confirmed

In this session, you will join a thought-provoking discussion on a topic that matters most to you. Take a seat at a table hosted by an industry or academic expert, where you’ll engage in informal conversation about a current hot topic.

Recovery has become as critical as training itself, and consumers increasingly seek targeted solutions to support rest, regeneration, and hydration. This session will delve into evidence‑based approaches to post‑exercise recovery, covering the rise of sleep‑support ingredients, the expanding role of botanicals in inflammation management and stress reduction, and the science behind optimal rehydration strategies.

More speakers to be confirmed

Attitudes toward body composition and weight management have undergone a significant shift, with modern goals incorporating metabolic health, muscle preservation, appetite regulation, and sustainable behaviour change. This session will explore new ingredient research, the influence of GLP‑1‑related consumer expectations, and ethical considerations around claims and messaging.  

More panellists to be confirmed